PA
NVO

Procyon Advisors’s Novo Nordisk NVO Stock Holding History

Procyon Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$569K Sell
11,861
-955
-7% -$41K 0.02% 343
2026
Q1 		$471K Buy
12,816
+805
+7% +$38.1K 0.02% 361
2025
Q4 		$611K Sell
12,011
-4,860
-29% -$249K 0.03% 320
2025
Q3 		$936K Sell
16,871
-1,602
-9% -$93.8K 0.06% 240
2025
Q2 		$1.27M Sell
18,473
-58,754
-76% -$4M 0.12% 160
2025
Q1 		$5.36M Buy
77,227
+21,756
+39% +$1.8M 0.32% 71
2024
Q4 		$4.77M Sell
55,471
-8,178
-13% -$884K 0.3% 75
2024
Q3 		$7.58M Buy
63,649
+4,010
+7% +$535K 0.52% 44
2024
Q2 		$8.51M Buy
59,639
+2,297
+4% +$304K 0.63% 40
2024
Q1 		$7.36M Buy
57,342
+2,316
+4% +$276K 0.57% 43
2023
Q4 		$5.69M Buy
55,026
+17,783
+48% +$1.76M 0.48% 43
2023
Q3 		$3.39M Buy
37,243
+19,701
+112% +$1.74M 0.35% 70
2023
Q2 		$1.42M Buy
17,542
+13,490
+333% +$1.1M 0.18% 130
2023
Q1 		$322K Buy
+4,052
New +$287K 0.05% 299
2020
Q3 		– Sell
-50
Closed -$2K – 759
2020
Q2 		$2K Buy
50
+8
+19% +$255 ﹤0.01% 940
2020
Q1 		$1K Sell
42
-38
-48% -$1.13K ﹤0.01% 940
2019
Q4 		$2K Buy
+80
New +$2.21K ﹤0.01% 898

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Procyon Advisors's NVO Position: Q2 2026 in Review

Procyon Advisors reduced its Novo Nordisk (NVO) stake by 7.5% in Q2 2026, selling an estimated $41K and leaving 11,861 shares worth $569K. The position accounts for 0.02% of the portfolio, ranked #343.

Procyon Advisors first reported a position in NVO in Q4 2019 and has held it in 17 quarters since. The position peaked at $8.51M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Procyon Advisors held 11,861 shares of Novo Nordisk worth $569K as of Q2 2026.
  • Procyon Advisors sold 955 Novo Nordisk shares in Q2 2026, an estimated $41K.
  • Novo Nordisk made up 0.02% of Procyon Advisors's portfolio in Q2 2026, its #343 holding.
  • Procyon Advisors first reported a position in Novo Nordisk in Q4 2019 and has held it in 17 quarters since.
  • Procyon Advisors's Novo Nordisk position peaked at $8.51M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.